There is a growing death burden from atrial fibrillation and flutter in low-income regions and younger populations, driven largely by metabolic risks such as high BMI.
May warrant vigilance for AFF in low-income youth; leaves open whether BMI reduction alters mortality.
The global death burden of AFF in low-income countries and younger generations have not been sufficiently controlled in the past and will continue growing in the future, which is largely attributed to metabolic risks, particularly for high BMI. There is an urgent need to implement effective measures to control AFF-related mortality.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: